At a glance
ClinicalIndex Comparison RecordN/ACompleted· 544 enrolled
Drug / intervention
Neurostimulation Systemdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
NAVITAS and ENVISION Study: A Study to Characterize the Relationship Between Select Objective Metrics and Clinical Outcomes in Chronic Pain Patients Treated With Boston Scientific Neurostimulation Systems
In Brief
A clinical study evaluating Neurostimulation System for Pain, Chronic. Completed, enrolled 544 participants across 16 sites.
Detailed Summary
The objective of the study is to characterize the relationship between select objective metrics and clinical outcomes in chronic pain patients treated with Boston Scientific commercially approved neurostimulation systems.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsPain, Chronic
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
201820192020202120222023202420252026
Enrollment StartJul 2017
First PostedAug 2017
Primary CompletionMar 2024
TodayJul 2026
First PostedAug 7, 2017
Enrollment StartJul 31, 2017
Primary CompletionMar 8, 2024
TodayJul 2, 2026
Enrollment to primary: 6.6 yearsPosted 8.9 years ago
Interventions
Neurostimulation Systemdevice
Spinal cord stimulation